TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32475079

Group type: EXPERIMENTAL
Intervention: Mepitel Film
Number of subjects: 39

Group type: COMPARATOR
Intervention: Biafine cream
Number of subjects: 39
Study: 34554368

Group type: EXPERIMENTAL
Intervention: CTO percutaneous coronary intervention (PCI)
Number of subjects: 174

Group type: COMPARATOR
Intervention: No CTO-PCI
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Baseline RV FWLS
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: RV GLS
Number of subjects: 174
Study: 33622408

Group type: EXPERIMENTAL
Intervention: Gratitude intervention program (1-month long)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 34380150

Group type: EXPERIMENTAL
Intervention: Upper body resistance training (60% of 1 repetition maximum (1RM), 3×10 repetitions, 6 exercise stations, 2 times per week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 18
Study: 32994187

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 338

Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 338
Study: 33467135

Group type: EXPERIMENTAL
Intervention: DHA-rich oil
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: EPA-rich oil
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 36208052

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lactose (placebo)
Number of subjects: 20
Study: 32544011

Group type: EXPERIMENTAL
Intervention: 200 mg CoQ10 capsules per day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 34488817

Group type: EXPERIMENTAL
Intervention: VMAT
Number of subjects: 30

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 30
Study: 32955672

Group type: EXPERIMENTAL
Intervention: Very Long Roux Limb LRYGB (VLRL‐LRYGB) (variable RL length, BPL 60 cm, and CC 100 cm)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Standard LRYGB (S‐LRYGB) (RL 150 cm, BPL 60 cm, and variable CC length)
Number of subjects: 444
Study: 36184601

Group type: EXPERIMENTAL
Intervention: L-BAIBA 1500 mg (B1500)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-BAIBA 500 mg (B500)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-BAIBA 250 mg (B250)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Valine 1500 mg (V1500)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 33455201

Group type: EXPERIMENTAL
Intervention: Non-fluorescent ELP fusion proteins co-transfected with a fluorescent ELP marker; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single transfected treatments of ELP fusions; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 32641320

Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa 1200 mg intravenously every 2 weeks
Number of subjects: 32
Study: 35128361

Group type: EXPERIMENTAL
Intervention: 30-day placement of balloon stent
Number of subjects: 91

Group type: COMPARATOR
Intervention: Intrauterine device (IUD)
Number of subjects: 91
Study: 33756279

Group type: EXPERIMENTAL
Intervention: 30 min of slumped sitting
Number of subjects: 15
Study: 35843919

Group type: EXPERIMENTAL
Intervention: Nasal cannula on 15L of oxygen (Group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal cannula on 6L of oxygen (Group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facemask on 15L of oxygen (Group IV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Facemask on 6L of oxygen (Group III)
Number of subjects: 0
Study: 33196146

Group type: EXPERIMENTAL
Intervention: 4.0-mm homogenous treatment zone
Number of subjects: 23

Group type: COMPARATOR
Intervention: 4.0-mm annular treatment zone
Number of subjects: 23
Study: 36148315

Group type: EXPERIMENTAL
Intervention: Restrictive postoperative antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liberal postoperative antibiotics
Number of subjects: 0
Study: 32561505

Group type: EXPERIMENTAL
Intervention: Functional Mobility training (n=33)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Mental/Leisure training (n=36)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Multimodal training (n=38)
Number of subjects: 107
Study: 32745639

Group type: EXPERIMENTAL
Intervention: Gluten challenge (PGC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Gluten-free diet (GFD)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Regression models using four gene transcripts
Number of subjects: 21
Study: 32100502

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy combined with rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine ASD rehabilitation training
Number of subjects: 60
Study: 34921121

Group type: EXPERIMENTAL
Intervention: Treatment arm (specific treatment not detailed)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 433
Study: 32187128

Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention in addition to routine nursing care
Number of subjects: 286

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 286
Study: 35525250

Group type: EXPERIMENTAL
Intervention: Tenecteplase (0.4 mg/kg)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Alteplase (0.9 mg/kg)
Number of subjects: 204
Study: 32985652

Group type: EXPERIMENTAL
Intervention: EG-1962 (600 mg nimodipine administered into the basal cisterns)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oral nimodipine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: EG-1962
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: EG-1962 and Oral nimodipine
Number of subjects: 6
Study: 33223426

Group type: EXPERIMENTAL
Intervention: 3 mg GSK958108
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 7 mg GSK958108
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 32004995

Group type: EXPERIMENTAL
Intervention: Dynamic footprints
Number of subjects: 461

Group type: COMPARATOR
Intervention: Static footprints
Number of subjects: 461
Study: 33865691

Group type: EXPERIMENTAL
Intervention: Extended-release buprenorphine (XR-B), n = 335
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX), n = 335
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Enhanced treatment as usual arm, n = 335
Number of subjects: 1005
Study: 32877576

Group type: EXPERIMENTAL
Intervention: rSARS-CoV-2 vaccine with Matrix-M1 adjuvant
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: rSARS-CoV-2 vaccine without Matrix-M1 adjuvant
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 35979596

Group type: COMPARATOR
Intervention: Conventional fluoroscopic guidance (CF group)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: EnSite Precision mapping system (zeroFluoro, ZF group)
Number of subjects: 123
Study: 35445990

Group type: EXPERIMENTAL
Intervention: Imrecoxib
Number of subjects: 126
Study: 32661940

Group type: EXPERIMENTAL
Intervention: Nonconvulsive electrotherapy (NET)
Number of subjects: 20
Study: 35403213

Group type: EXPERIMENTAL
Intervention: Single dose of fresh cow's milk (ED05)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 60
Study: 35032128

Group type: EXPERIMENTAL
Intervention: Serum leptin concentration in individuals with BMI > 40 kg/m2
Number of subjects: 109

Group type: COMPARATOR
Intervention: Serum leptin concentration in overweight individuals
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Serum leptin levels in women
Number of subjects: 109

Group type: COMPARATOR
Intervention: Serum leptin levels in men
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with insulin
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with HOMA-IR
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of leptin level with BMI
Number of subjects: 109
Study: 32421440

Group type: EXPERIMENTAL
Intervention: Minimally Invasive Esophagectomy (MIE)
Number of subjects: 4720

Group type: COMPARATOR
Intervention: Inclusion in the TIME trial
Number of subjects: 4720
Study: 34568974

Group type: EXPERIMENTAL
Intervention: Non-periodized group (NG)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Linear periodized group (PG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 69
Study: 32706977

Group type: EXPERIMENTAL
Intervention: CT radiomics prediction model
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional contrast-enhanced CT (CECT)
Number of subjects: 119
Study: 32975823

Group type: EXPERIMENTAL
Intervention: Thermal suit with FAW unit set to 38°C
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hospital clothes with lower body blanket set to 38°C and warming mattress set to 37°C
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thermal suit with FAW unit
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hospital clothes with lower body blanket and warming mattress
Number of subjects: 40
Study: 33069667

Group type: EXPERIMENTAL
Intervention: Parental Coaching (SG; n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Routine follow-up (CG; n=9)
Number of subjects: 18
Study: 36099876

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) with sodium ferrous citrate (SFC)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 34852693

Group type: EXPERIMENTAL
Intervention: Body mass-based resistance training (bmRT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 46
Study: 36331328

Group type: EXPERIMENTAL
Intervention: Camrelizumab plus chemotherapy
Number of subjects: 144

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 144
Study: 34006921

Group type: EXPERIMENTAL
Intervention: Tesamorelin
Number of subjects: 0
Study: 32620370

Group type: EXPERIMENTAL
Intervention: 3D‐printed ear splint
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional thermoplastic ear splint
Number of subjects: 40
Study: 36206152

Group type: EXPERIMENTAL
Intervention: Anthocyanin intake (ATH group) - daily intake of açaí‐juçara 200 g (anthocyanins 293.6 mg) for 12 weeks.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-anthocyanin intake (N-ATH group) - 12-week individualized diet plan with 20% reduction in total energy intake.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups (ATH and N-ATH)
Number of subjects: 55
Study: 33713385

Group type: EXPERIMENTAL
Intervention: World Health Organization growth standards
Number of subjects: 683

Group type: COMPARATOR
Intervention: China growth charts
Number of subjects: 683
Study: 32245644

Group type: EXPERIMENTAL
Intervention: School-based educational intervention (45-minute lecture on HPV and HPV vaccine knowledge)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control classes (no educational intervention)
Number of subjects: 0
Study: 34907617

Group type: EXPERIMENTAL
Intervention: 20 µg Clobetasol patch (Rivelin® ‐CLO), twice daily, for 4 weeks
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: 20 µg Clobetasol patch (Rivelin® ‐CLO)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo (nonmedicated)
Number of subjects: 138
Study: 32577847

Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasound
Number of subjects: 6

Group type: COMPARATOR
Intervention: Macroscopic evaluation by the surgeon
Number of subjects: 6
Study: 35176724

Group type: EXPERIMENTAL
Intervention: Wii Fit training (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual school program (n = 25)
Number of subjects: 50
Study: 32878959

Group type: EXPERIMENTAL
Intervention: Physiotherapy programme comprising thoracic and shoulder girdle exercises
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 19
Study: 33150385

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 92
Study: 32110882

Group type: EXPERIMENTAL
Intervention: Ketamine (0.15 mg/kg (LBM))
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 32
Study: 33483508

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32471492

Group type: EXPERIMENTAL
Intervention: Administration of Patient Health Questionnaire (PHQ‐9) as a PROM within 2 weeks of diagnosis and at follow‐up 4 weeks later. General practitioners trained in interpreting scores and providing feedback.
Number of subjects: 676
Study: 36394384

Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 8246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study: 34628740

Group type: EXPERIMENTAL
Intervention: Deep needling at Xiaguan (ST 7) with round sharp needle combined with plum-blossom needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study: 36014800

Group type: EXPERIMENTAL
Intervention: Anti-Inflammatory Diet (AID)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Canada’s Food Guide (CFG)
Number of subjects: 53
Study: 36173391

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Strengthening exercise
Number of subjects: 8
Study: 34159451

Group type: EXPERIMENTAL
Intervention: Extremely Randomized Trees (ERT) model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multivariate Adaptive Regression Splines (MARS) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factors controlling DEF identified by ERT model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factors affecting IDEF identified by ERT model
Number of subjects: 0
Study: 32928387

Group type: EXPERIMENTAL
Intervention: Hydrophobic SERS substrate prepared by spin-coating lubricating liquid onto commercial paper.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrophobic SERS substrate
Number of subjects: 0
Study: 35972742

Group type: EXPERIMENTAL
Intervention: Commercial weight management program
Number of subjects: 373

Group type: COMPARATOR
Intervention: Do-It-Yourself (DIY) approach
Number of subjects: 373
Study: 32526916

Group type: EXPERIMENTAL
Intervention: Tibialis anterior taping
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Calf taping
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nontaping condition
Number of subjects: 20
Study: 34982321

Group type: EXPERIMENTAL
Intervention: Information film about Oncotype DX
Number of subjects: 120

Group type: COMPARATOR
Intervention: Information leaflet about Oncotype DX
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Information film about Prosigna
Number of subjects: 120

Group type: COMPARATOR
Intervention: Information leaflet about Prosigna
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Reading leaflets first, then viewing films
Number of subjects: 120

Group type: COMPARATOR
Intervention: Viewing films first, then reading leaflets
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preference for films
Number of subjects: 120
Study: 33421682

Group type: EXPERIMENTAL
Intervention: TLT-based debriefing protocol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (gather-analyze-summarize-based debriefing)
Number of subjects: 56
Study: 35553804

Group type: EXPERIMENTAL
Intervention: CBD (50mg/day with 175mg of MCT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (coconut derived MCT; 225mg/day)
Number of subjects: 14
Study: 32061417

Group type: EXPERIMENTAL
Intervention: Kinesio taping (Kinesio Tex)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no taping)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 34
Study: 34958456

Group type: EXPERIMENTAL
Intervention: Reminder group (N=26)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Non-reminder group (N=28)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (N=27)
Number of subjects: 81
Study: 32441845

Group type: EXPERIMENTAL
Intervention: Sirius minimally invasive bone reduction handle system (SMH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Traditional Kern forceps only (KO)
Number of subjects: 8
Study: 35909461

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2% eye drops solution (Rompharm Company SRL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Trusopt® eye drops solution
Number of subjects: 32
Study: 33249909

Group type: EXPERIMENTAL
Intervention: Collared femoral stem (n = 23)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Collarless femoral stem (n = 26)
Number of subjects: 49
Study: 33387930

Group type: EXPERIMENTAL
Intervention: EMS treatments
Number of subjects: 342

Group type: COMPARATOR
Intervention: Comparison with published treatment time data from other EMS systems
Number of subjects: 342
Study: 32001832

Group type: EXPERIMENTAL
Intervention: Neoadjuvant endocrine therapy (NET) with anastrozole and fulvestrant
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Neoadjuvant endocrine therapy (NET)
Number of subjects: 236
Study: 34154898

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) training in addition to passive ROM and stretch exercises
Number of subjects: 22

Group type: COMPARATOR
Intervention: Passive ROM and stretch exercises (Control)
Number of subjects: 22
Study: 33245708

Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music once a day)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music twice a day)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 126
Study: 35469036

Group type: EXPERIMENTAL
Intervention: LIFT + BM-MNC injection
Number of subjects: 70

Group type: COMPARATOR
Intervention: LIFT alone
Number of subjects: 70
Study: 34673954

Group type: EXPERIMENTAL
Intervention: 1% HNa + 1% Gln
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3% HNa + 1% Gln
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% HNa + 1% Gln
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% HNa + 1% Gln (Exp. 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basal diet (Control)
Number of subjects: 60
Study: 34253600

Group type: EXPERIMENTAL
Intervention: Community monitoring of the forest
Number of subjects: 110
Study: 32382784

Group type: EXPERIMENTAL
Intervention: SNPs (rs938112, rs2987902) in genes LSMAP and ABL1
Number of subjects: 356
Study: 35710450

Group type: EXPERIMENTAL
Intervention: Advanced Care at Home (ACH)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Traditional inpatient care
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: ACH
Number of subjects: 360
Study: 33539980

Group type: EXPERIMENTAL
Intervention: Hip arthroscopy intervention (specific details not provided)
Number of subjects: 8
Study: 32097825

Group type: EXPERIMENTAL
Intervention: Positive interpretation training
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Negative interpretation training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cognitive load during training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no cognitive load)
Number of subjects: 71
Study: 36123681

Group type: EXPERIMENTAL
Intervention: Complete vaccination with Gam-COVID-Vac (14 days or more after the second dose)
Number of subjects: 13893
Study: 34322891

Group type: EXPERIMENTAL
Intervention: Pocket ultrasound device (PUD)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional ultrasound device (CUD)
Number of subjects: 86
Study: 33605177

Group type: EXPERIMENTAL
Intervention: Emotional IC training program
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Neutral IC training program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlisted control
Number of subjects: 42
Study: 33683300

Group type: EXPERIMENTAL
Intervention: Combination of conservative treatments (education on self-management and ergonomic principles, base-of-thumb splint, hand exercises, diclofenac sodium 1% gel)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Education on self-management and ergonomic principles alone (comparator group)
Number of subjects: 204
Study: 32757131

Group type: EXPERIMENTAL
Intervention: Index-based approach to assess flood disaster resilience
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physical conditions, human resources, institutional issues, and external relationships
Number of subjects: 20
Study: 34864943

Group type: EXPERIMENTAL
Intervention: Maribavir 400 mg twice daily
Number of subjects: 352

Group type: COMPARATOR
Intervention: Investigator-assigned therapy (IAT; valganciclovir/ganciclovir, foscarnet, or cidofovir)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Foscarnet
Number of subjects: 352

Group type: COMPARATOR
Intervention: Valganciclovir/ganciclovir
Number of subjects: 352
Study: 33546752

Group type: EXPERIMENTAL
Intervention: ActionADE intervention transmitting information to PharmaNet
Number of subjects: 3600

Group type: COMPARATOR
Intervention: Control arm with ActionADE retaining information in the local record
Number of subjects: 3600
Study: 35809742

Group type: EXPERIMENTAL
Intervention: Ropivacaine infusion via TAP catheter
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33748067

Group type: EXPERIMENTAL
Intervention: Health literacy assessment using the HLS-EU-Q16
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Health literacy assessment
Number of subjects: 322
Study: 32825845

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (group sessions, telephone consultations, behavior design, hotline, buddy-matching)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Low-intensity intervention (standard treatment, guideline-based municipal smoking cessation program)
Number of subjects: 600
Study: 35549926

Group type: EXPERIMENTAL
Intervention: Increased disgust sensitivity to pathogen stimuli
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Dangerousness attributions in the description of SMI
Number of subjects: 271
Study: 33115322

Group type: EXPERIMENTAL
Intervention: Self-selected resistance training (SSRT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 32402832

Group type: EXPERIMENTAL
Intervention: NOSE group (n=122)
Number of subjects: 276

Group type: COMPARATOR
Intervention: non-NOSE group (n=119)
Number of subjects: 276
Study: 33769163

Group type: COMPARATOR
Intervention: Parental depressive symptoms
Number of subjects: 90

Group type: COMPARATOR
Intervention: Guilt induction
Number of subjects: 90

Group type: COMPARATOR
Intervention: Positive parenting practices
Number of subjects: 90

Group type: COMPARATOR
Intervention: Family cohesion
Number of subjects: 90

Group type: COMPARATOR
Intervention: Interparental conflict
Number of subjects: 90